Evidence mapPaperPMID 40598015Full record

ArticleBMC psychiatry2025

A framework for parsing psychopathological heterogeneity: initial application in a large-scale unselected community sample.

Chaoyi Wu, Chenyu Yuan, Yinqing Fan, Ang Hong, Zhiling Wu, Zhen Wang

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chaoyi WuShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, P.R. China.
Chenyu YuanShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, P.R. China.
Yinqing FanShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, P.R. China.
Ang HongShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, P.R. China.
Zhiling WuDepartment of Psychology, Sun Yat-Sen University, Guangzhou, P.R. China.
Zhen WangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, P.R. China. wangzhen@smhc.org.cn.

Funding

Shanghai Municipal Health Commission 2019ZB0201
6 · The paper itself

Abstract

backgroundTraditional descriptive nosology arbitrarily distinguishes between mental illness and health, hindering the progress of scientific research and clinical practice. Building on recent advancements in psychiatric conceptualization, this study proposes an innovative phased framework for deconstructing psychopathological heterogeneity. The framework involves four key steps: extraction of symptom dimensions, identification of psychopathological subtypes, characterization of symptom interaction patterns using a network approach, and validation of their incremental validity through links to neurobehavioral functions. This framework is preliminarily applied to a large, non-selective community sample (N = 4102) to explore its utility and potential for deconstructing psychopathological heterogeneity.

methodsData on comprehensive psychopathology and RDoC negative valence constructs were collected from the sample. Factor analysis and exploratory graph analysis were used to extract symptom dimensions. Latent profile analysis based on these dimensions was applied to identify psychopathological profiles. Partial correlation networks were estimated for each profile, and symptom network characteristics were compared across profiles. Finally, hierarchical multiple regression was applied to assess incremental validity.

resultsThe first step of the phased framework involves extracting homogeneous dimensions based on symptom co-occurrence patterns, yielding seven distinct dimensions: Obsessive-Compulsive, Emotional Distress, Eating-Related, Substance-Related, Aggressive, Psychotic, and Somatoform dimensions. The second step involves applying a person-centered approach to identify latent subgroups based on these symptom dimensions. Four profiles were identified, namely Substance Use Group, Moderate Symptomatology Group, Disengaged from Symptomatology Group, and Severe Symptomatology Group. The third step involves characterizing symptom interaction patterns across subgroups. Using a network approach, the Severe Symptomatology Group exhibited the densest interconnections and the highest global network strength, with Aggressive and Psychotic dimensions serving as core issues compared to other profiles. Finally, incremental validity was assessed through associations with self-reported neurobehavioral functions. Results showed that these profiles provided unique predictive value for RDoC negative valence constructs beyond both dichotomous diagnostic status and purely dimensional approach.

conclusionsThis study introduces a fine-grained framework for deconstructing psychopathological heterogeneity, providing a comprehensive approach to parsing psychopathology. While the framework is preliminarily applied to a large sample from the Chinese population, future studies should integrate multimodal neurobehavioral measures, employ intensive longitudinal designs to track symptom dynamics, and validate its consistency across diverse cultural and regional contexts.

Indexed as

Mental DisordersAdolescentAdultFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedPsychopathologyYoung AdultDimensional approachHeterogeneityNetwork approachPerson-centered approachPsychopathology

Identifiers

PMID40598015
PMCPMC12210741

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.